Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice
about
Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice.Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsBehavioral genetic contributions to the study of addiction-related amphetamine effects.Alcoholism and alternative splicing of candidate genesIntronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.Increased consumption of ethanol and sugar water in mice lacking the dopamine D2 long receptor.Novel antipsychotics in schizophrenia.mRNA transcript diversity creates new opportunities for pharmacological intervention.Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor AgonistEmotional response in dopamine D2L receptor-deficient mice.Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.Role of iso-receptors in receptor-receptor interactions with a focus on dopamine iso-receptor complexes.The Conserved Arginine Cluster in the Insert of the Third Cytoplasmic Loop of the Long Form of the D₂ Dopamine Receptor (D2L-R) Acts as an Intracellular Retention Signal.Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain.Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice.
P2860
Q30364690-9B2FA5F4-A078-42F1-B094-47B996606554Q30476572-332327AC-6757-464C-962B-046BCA250550Q30476813-28072EBE-CBEC-473F-88B7-8DD000403F54Q30494693-B6BF3E90-9968-4D28-8BE4-A81C0F2D8039Q33859015-D724B4D5-6B77-4DD7-9EBF-26B83DE708F1Q34662050-75D3E4C0-E65B-48B2-AC77-763BFA271661Q35250723-44527626-5E43-4FF6-B57E-458022C8F762Q35753453-14BF2B30-C285-47B7-B2BF-3C331099194CQ35913120-96D3FD33-C8F0-42EC-9959-17626F9FD05FQ36733481-C84A46B3-55C3-4A54-9ABD-7F2F933A7EF1Q37161661-D44296DA-95F6-4C75-88A8-4806F969D375Q37910743-3DE263BC-F11B-4CEB-B145-F6E2693A3BEDQ38595178-45FFA281-3D75-40F3-A4B7-C0E13403D195Q39570856-904A037B-B714-4899-81E9-C6C12CB2FE50Q43868487-F4FC75E7-8FAE-4953-A7BA-F5E85D5AAD23Q50760658-FB09D911-7B97-45DB-94B6-04062C46657F
P2860
Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Januar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/01/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/01/01)
@nl
наукова стаття, опублікована в січні 2002
@uk
مقالة علمية (نشرت عام 2002)
@ar
name
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@ast
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@en
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@nl
type
label
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@ast
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@en
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@nl
prefLabel
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@ast
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@en
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@nl
P2093
P2860
P3181
P356
P1433
P1476
Dopamine D2S and D2L receptors ...... c and psychotic agents in mice
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/SJ.MP.4001145
P407
P577
2002-01-01T00:00:00Z